Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 23, 2016

Study Completion Date

September 23, 2016

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

dimethyl fumarate

Trial Locations (12)

15462

Research Site, Dasman

37075

Research Site, Göttingen

80337

Research Site, München

92408

Research Site, San Bernardino

B-9000

Research Site, Ghent

B-1113

Research Site, Sofia

500 05

Research Site, Hradec Králové

LV-1004

Research Site, Riga

1107 2020

Research Site, Beirut

80-952

Research Site, Gdansk

60-355

Research Site, Poznan

06100

Research Site, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY